Hematology & Oncology Doctors in Monterey, CA Accepting Medicare

9 Hematology & Oncology doctors found. Showing 1 - 9

Nancy Rubin, D.O. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Harris Ct, Bldg T, 2nd Fl Suite 201, Monterey, CA 93940 Phone: 831-375-4105

Roger Shiffman, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Harris Ct, Bldg T, 2nd Floor Suite 201, Monterey, CA 93940 Phone: 831-375-4105    Fax: 831-372-5722

Heather Dianne Cunningham, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 80 Garden Ct Ste 200, Monterey, CA 93940 Phone: 831-920-3500    Fax: 831-920-3600

Kent Bransford, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5 Harris Ct Bldg T, 2nd Floor # 201, Monterey, CA 93940 Phone: 831-375-4105    Fax: 831-372-5722

Dr. Grant Swanson, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 23625 Holman Hwy, Cancer Center, Monterey, CA 93940 Phone: 831-622-2749

Laura Stampleman, M.D Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5 Harris Court, Building T, Suite 201, Monterey, CA 93940 Phone: 831-375-4105    Fax: 831-372-5722

Arina D Golubeva-ganeles, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 700 Cass St. Suite 128, Monterey, CA 93940 Phone: 831-920-3222    Fax: 831-920-3245

Thomas Patrick Bradley, MD, PHD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 24571 Silver Cloud Ct, Suite 201, Monterey, CA 93940 Phone: 831-333-1719    Fax: 831-333-0442

Ping Hu, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Harris Ct Bldg T #201, Monterey, CA 93940 Phone: 831-375-4105    Fax: 831-372-5722

News Archive

BioMarin Pharmaceutical receives FDA orphan drug designation for 3,4-DAP

BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.

New project to seek answers for effects of alcohol on the nervous system

When a drink at the local watering hole turns into five or six, what are the effects on our brains and hearts? How does too much to drink affect how we sleep? How does binge drinking affect blood pressure for people who drink socially but not usually to excess? Do women's bodies process alcohol differently depending on stages of their menstrual cycles?

Foreign Prison Conditions Improvement Act introduced in Senate

Sens. Patrick Leahy (D-Vt.) and James Inhofe (R-Okla.) last week introduced the Foreign Prison Conditions Improvement Act, which "would set standards for humane conditions [in prisons globally], require the Secretary of State to report on prison conditions in at least 30 countries receiving U.S. assistance or under U.S. sanctions, engage governments in recognizing and remedying human rights abuses behind bars and open the door to foreign aid to assist in bringing improvements,"

Follow-up program for high-risk patients appears to detect melanomas at early stages

A follow-up program for patients at high risk of developing skin cancer appears to be associated with the detection of melanomas at early stages and with good prognosis, according to a report posted online today that will appear in the May print issue of Archives of Dermatology, one of the JAMA/Archives journals.

Blog examines gap between mental health disease burden, attention given to problem

This post in KPLU's "Humanosphere" blog examines the "gap between the disease burden of mental illness and the amount of funding and attention devoted to solving the problem," referencing a post published Friday in the Global Health Interest Forum's "Blog of Scientists for Global Health," written by Paul Southworth, a visiting scholar on malaria and vaccine science at the NIH.

Read more Medical News

› Verified 8 days ago